Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use.
Kwon
Paul
P
San Antonio Uniformed Services Health Education Consortium, San Antonio, Texas, USA. kwonp@yahoo.com
Lefkowitz
William
W
D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000175:diagnosis* / Q000188:drug therapy; D015283:Citalopram / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008140:Lorazepam / Q000627:therapeutic use; D008429:Maternal Welfare; D017294:Ondansetron / Q000009:adverse effects*; D010634:Phenobarbital / Q000627:therapeutic use; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced / Q000175:diagnosis* / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D014151:Anti-Anxiety Agents; D015283:Citalopram; D008140:Lorazepam; D017294:Ondansetron; D010634:Phenobarbital; D017367:Selective Serotonin Reuptake Inhibitors